Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of tumor type with the potential to have P-cadherin expression that is resistant to standard therapy or for which no standard therapy is available
Performance status of 0 or 1
Adequate bone marrow, kidney and liver function
You may not be if
Known CNS disease including, but not limited to, metastases
Current or history of seizure disorder
History of or active autoimmune disorders
Active bacterial, fungal or viral infection
Major surgery, anti-cancer therapy, or radiation therapy within 4 weeks of study treatment
Requirement for systemic immune suppressive medication
Grade 2 or greater peripheral neuropathy
Clareo Health | PF-06671008 Dose Escalation Study in Advanced Solid Tumors
